Connection

MIGUEL CRUZ to Humans

This is a "connection" page, showing publications MIGUEL CRUZ has written about Humans.
Connection Strength

0.444
  1. The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma. Blood Coagul Fibrinolysis. 2024 Jul 01; 35(5):256-264.
    View in: PubMed
    Score: 0.024
  2. A novel interaction between extracellular vimentin and fibrinogen in fibrin formation. Thromb Res. 2023 01; 221:97-104.
    View in: PubMed
    Score: 0.021
  3. Aberrant Fibrin Clot Structure Visualized Ex Vivo in Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Crit Care Med. 2022 06 01; 50(6):e557-e568.
    View in: PubMed
    Score: 0.020
  4. Public health branch incident management and support as part of the Federal Government response during the emergency phase of Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands. J Emerg Manag. 2022 Special Issue On Puerto Rico; 19(8):63-77.
    View in: PubMed
    Score: 0.020
  5. The vimentin rod domain blocks P-selectin-P-selectin glycoprotein ligand 1 interactions to attenuate leukocyte adhesion to inflamed endothelium. PLoS One. 2020; 15(10):e0240164.
    View in: PubMed
    Score: 0.019
  6. Recombinant Human Vimentin Binds to P-Selectin and Blocks Neutrophil Capture and Rolling on Platelets and Endothelium. J Immunol. 2018 03 01; 200(5):1718-1726.
    View in: PubMed
    Score: 0.015
  7. Admixture mapping in two Mexican samples identifies significant associations of locus ancestry with triglyceride levels in the BUD13/ZNF259/APOA5 region and fine mapping points to rs964184 as the main driver of the association signal. PLoS One. 2017; 12(2):e0172880.
    View in: PubMed
    Score: 0.014
  8. Assessing the Congregate Disaster Shelter: Using Shelter Facility Assessment Data for Evaluating Potential Hazards to Occupants During Disasters. J Public Health Manag Pract. 2017 Jan/Feb; 23(1):54-58.
    View in: PubMed
    Score: 0.014
  9. Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices. Blood. 2015 Nov 12; 126(20):2338-41.
    View in: PubMed
    Score: 0.013
  10. A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia. Thromb Res. 2015 May; 135(5):1025-30.
    View in: PubMed
    Score: 0.013
  11. Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress. Blood. 2014 Apr 24; 123(17):2715-21.
    View in: PubMed
    Score: 0.012
  12. N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress. J Biol Chem. 2012 Apr 27; 287(18):14579-85.
    View in: PubMed
    Score: 0.010
  13. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. J Thromb Haemost. 2007 Jul; 5(7):1363-70.
    View in: PubMed
    Score: 0.007
  14. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. J Thromb Haemost. 2006 Feb; 4(2):417-25.
    View in: PubMed
    Score: 0.007
  15. Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage. Cancer Epidemiol Biomarkers Prev. 2025 Feb 06; 34(2):234-245.
    View in: PubMed
    Score: 0.006
  16. The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain. Blood. 2005 Mar 01; 105(5):1986-91.
    View in: PubMed
    Score: 0.006
  17. Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow. J Thromb Haemost. 2004 Aug; 2(8):1460-6.
    View in: PubMed
    Score: 0.006
  18. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate. J Thromb Haemost. 2004 Mar; 2(3):485-91.
    View in: PubMed
    Score: 0.006
  19. Trans-ancestral genome-wide association study of longitudinal pubertal height growth and shared heritability with adult health outcomes. Genome Biol. 2024 01 16; 25(1):22.
    View in: PubMed
    Score: 0.006
  20. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate. Thromb Haemost. 2003 Dec; 90(6):1204-9.
    View in: PubMed
    Score: 0.006
  21. Platelet aggregation by membrane-expressed A1 domains of von Willebrand Factor is dependent on residues Asp 560 and Gly 561. Biochem Biophys Res Commun. 2003 Mar 21; 302(4):873-7.
    View in: PubMed
    Score: 0.005
  22. High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19. J Thromb Thrombolysis. 2022 Aug; 54(2):211-216.
    View in: PubMed
    Score: 0.005
  23. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet. 2022 05; 54(5):560-572.
    View in: PubMed
    Score: 0.005
  24. Genome-wide association study of body fat distribution traits in Hispanics/Latinos from the HCHS/SOL. Hum Mol Genet. 2021 11 01; 30(22):2190-2204.
    View in: PubMed
    Score: 0.005
  25. Thromboelastography MightBe More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19. J Am Coll Surg. 2021 06; 232(6):1021-1022.
    View in: PubMed
    Score: 0.005
  26. The MC4R p.Ile269Asn mutation confers a high risk for type 2 diabetes in the Mexican population via obesity dependent and independent effects. Sci Rep. 2021 02 04; 11(1):3097.
    View in: PubMed
    Score: 0.005
  27. Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice. Blood. 2021 01 28; 137(4):544-555.
    View in: PubMed
    Score: 0.005
  28. Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:1076029621992128.
    View in: PubMed
    Score: 0.005
  29. Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19. J Am Coll Surg. 2021 02; 232(2):227-229.
    View in: PubMed
    Score: 0.005
  30. Links between thrombosis and inflammation in traumatic brain injury. Thromb Res. 2021 02; 198:62-71.
    View in: PubMed
    Score: 0.005
  31. Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain. J Biol Chem. 2000 Jun 23; 275(25):19098-105.
    View in: PubMed
    Score: 0.005
  32. Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill. JAMA Netw Open. 2020 06 01; 3(6):e2011192.
    View in: PubMed
    Score: 0.005
  33. Mapping the collagen-binding site in the I domain of the glycoprotein Ia/IIa (integrin alpha(2)beta(1)). J Biol Chem. 2000 Feb 11; 275(6):4205-9.
    View in: PubMed
    Score: 0.004
  34. Genome-wide meta-analysis associates GPSM1 with type 2 diabetes, a plausible gene involved in skeletal muscle function. J Hum Genet. 2020 Apr; 65(4):411-420.
    View in: PubMed
    Score: 0.004
  35. Functional analysis of a recombinant glycoprotein Ia/IIa (Integrin alpha(2)beta(1)) I domain that inhibits platelet adhesion to collagen and endothelial matrix under flow conditions. J Biol Chem. 1999 Dec 10; 274(50):35921-6.
    View in: PubMed
    Score: 0.004
  36. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease. J Mol Biol. 2020 01 17; 432(2):305-323.
    View in: PubMed
    Score: 0.004
  37. Domain-specific mechanical modulation of VWF-ADAMTS13 interaction. Mol Biol Cell. 2019 07 22; 30(16):1920-1929.
    View in: PubMed
    Score: 0.004
  38. In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion. J Thromb Haemost. 2019 06; 17(6):866-877.
    View in: PubMed
    Score: 0.004
  39. Functionally oriented analysis of cardiometabolic traits in a trans-ethnic sample. Hum Mol Genet. 2019 04 01; 28(7):1212-1224.
    View in: PubMed
    Score: 0.004
  40. Genetic polymorphisms associated with pediatric-onset type 2 diabetes: A family-based transmission disequilibrium test and case-control study. Pediatr Diabetes. 2019 05; 20(3):239-245.
    View in: PubMed
    Score: 0.004
  41. Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies. Nat Commun. 2019 01 03; 10(1):29.
    View in: PubMed
    Score: 0.004
  42. Characterization of Large Copy Number Variation in Mexican Type 2 Diabetes subjects. Sci Rep. 2017 12 06; 7(1):17105.
    View in: PubMed
    Score: 0.004
  43. Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices. ASAIO J. 2017 Nov/Dec; 63(6):849-853.
    View in: PubMed
    Score: 0.004
  44. Genetic architecture of lipid traits in the Hispanic community health study/study of Latinos. Lipids Health Dis. 2017 Oct 12; 16(1):200.
    View in: PubMed
    Score: 0.004
  45. Disruption of protein complexes containing protein phosphatase?2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells. J Thromb Haemost. 2017 05; 15(5):1032-1039.
    View in: PubMed
    Score: 0.004
  46. A Novel Interaction of the Catalytic Subunit of Protein Phosphatase 2A with the Adaptor Protein CIN85 Suppresses Phosphatase Activity and Facilitates Platelet Outside-in aIIb?3 Integrin Signaling. J Biol Chem. 2016 08 12; 291(33):17360-8.
    View in: PubMed
    Score: 0.003
  47. Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica. 2016 07; 101(7):e277-9.
    View in: PubMed
    Score: 0.003
  48. Meta-analysis of lipid-traits in Hispanics identifies novel loci, population-specific effects, and tissue-specific enrichment of eQTLs. Sci Rep. 2016 Jan 19; 6:19429.
    View in: PubMed
    Score: 0.003
  49. JBASE: Joint Bayesian Analysis of Subphenotypes and Epistasis. Bioinformatics. 2016 Jan 15; 32(2):203-10.
    View in: PubMed
    Score: 0.003
  50. Hemoglobin interaction with GP1ba induces platelet activation and apoptosis: a novel mechanism associated with intravascular hemolysis. Haematologica. 2015 Dec; 100(12):1526-33.
    View in: PubMed
    Score: 0.003
  51. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin. 2015 Oct; 31(4):661-74.
    View in: PubMed
    Score: 0.003
  52. Von Willebrand factor-A1 domain binds platelet glycoprotein Iba in multiple states with distinctive force-dependent dissociation kinetics. Thromb Res. 2015 Sep; 136(3):606-12.
    View in: PubMed
    Score: 0.003
  53. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem. 1995 May 05; 270(18):10822-7.
    View in: PubMed
    Score: 0.003
  54. Elevated Levels of LDL-C are Associated With ApoE4 but Not With the rs688 Polymorphism in the LDLR Gene. Clin Appl Thromb Hemost. 2016 Jul; 22(5):465-70.
    View in: PubMed
    Score: 0.003
  55. Cross-tissue and tissue-specific eQTLs: partitioning the heritability of a complex trait. Am J Hum Genet. 2014 Nov 06; 95(5):521-34.
    View in: PubMed
    Score: 0.003
  56. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem. 1993 Oct 05; 268(28):21238-45.
    View in: PubMed
    Score: 0.003
  57. Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor. J Biol Chem. 2013 Nov 15; 288(46):33118-23.
    View in: PubMed
    Score: 0.003
  58. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Iba. J Biol Chem. 2013 Nov 08; 288(45):32289-32301.
    View in: PubMed
    Score: 0.003
  59. Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood. 2013 Nov 21; 122(22):3632-41.
    View in: PubMed
    Score: 0.003
  60. The interaction between factor H and Von Willebrand factor. PLoS One. 2013; 8(8):e73715.
    View in: PubMed
    Score: 0.003
  61. The linker between the D3 and A1 domains of vWF suppresses A1-GPIba catch bonds by site-specific binding to the A1 domain. Protein Sci. 2013 Aug; 22(8):1049-59.
    View in: PubMed
    Score: 0.003
  62. Histone induced platelet aggregation is inhibited by normal albumin. Thromb Res. 2013 Jul; 132(1):69-76.
    View in: PubMed
    Score: 0.003
  63. Reconstitution of the platelet glycoprotein Ib-IX complex in phospholipid bilayer Nanodiscs. Biochemistry. 2011 Dec 13; 50(49):10598-606.
    View in: PubMed
    Score: 0.002
  64. GPIba-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease. Biophys J. 2011 Jan 19; 100(2):304-12.
    View in: PubMed
    Score: 0.002
  65. Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress. J Biol Chem. 2010 Jul 23; 285(30):22831-9.
    View in: PubMed
    Score: 0.002
  66. Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13. Blood. 2010 Jan 14; 115(2):370-8.
    View in: PubMed
    Score: 0.002
  67. Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha. Biophys J. 2009 Jul 22; 97(2):618-27.
    View in: PubMed
    Score: 0.002
  68. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost. 2009 Jun; 101(6):1070-7.
    View in: PubMed
    Score: 0.002
  69. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest. 2008 Sep; 118(9):3195-207.
    View in: PubMed
    Score: 0.002
  70. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions. Thromb Haemost. 2008 Mar; 99(3):586-93.
    View in: PubMed
    Score: 0.002
  71. Conformational stability and domain unfolding of the Von Willebrand factor A domains. J Mol Biol. 2007 Feb 23; 366(3):986-1000.
    View in: PubMed
    Score: 0.002
  72. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood. 2006 Jan 15; 107(2):423-30.
    View in: PubMed
    Score: 0.002
  73. Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor. Biophys J. 2005 Jun; 88(6):4391-401.
    View in: PubMed
    Score: 0.002
  74. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1. Blood. 2004 Dec 15; 104(13):3971-8.
    View in: PubMed
    Score: 0.002
  75. Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation. J Thromb Haemost. 2004 Apr; 2(4):660-9.
    View in: PubMed
    Score: 0.001
  76. Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion. J Thromb Haemost. 2003 Jun; 1(6):1150-7.
    View in: PubMed
    Score: 0.001
  77. Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. J Thromb Haemost. 2003 Jun; 1(6):1288-95.
    View in: PubMed
    Score: 0.001
  78. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem. 2003 Aug 08; 278(32):29633-9.
    View in: PubMed
    Score: 0.001
  79. Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med. 2002 Oct 21; 196(8):1057-66.
    View in: PubMed
    Score: 0.001
  80. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure. 2002 Jul; 10(7):943-50.
    View in: PubMed
    Score: 0.001
  81. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002 Jun 01; 99(11):3971-7.
    View in: PubMed
    Score: 0.001
  82. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood. 1997 Dec 01; 90(11):4425-37.
    View in: PubMed
    Score: 0.001
  83. Glycoprotein Ib can mediate endothelial cell attachment to a von Willebrand factor substratum. Thromb Haemost. 1995 Feb; 73(2):309-17.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.